SpaceX's first profitable quarter, with about $16.4B of AI-related spending in a single quarter, argues against the view that AI funding has peaked. It supports the thesis that AI, robotics, space and biotech drive abundance. The market still prices the AI hardware chain at 4–14x forward PE, which implies it expects earnings to peak. High-valuation names such as ISRG showed how little room they have for margin slips.
Key signals
- SpaceX Q3 revenue was about $14.6B (+161%, versus consensus of about $12.7B). Net income was about $4.4B, its first profit since listing. Shares rose 8.06% after hours to 159.70.
- The SOX index closed at 11,283.8 on 10-20, down 14.6% from its 10-06 high of 13,217.8. Chip stocks rebounded 2–4% after hours. Forward PE is 13.6 for NVDA and 4.3 for MU. SpaceX is reportedly raising $40B of debt to buy Nvidia chips.
- ISRG Q3 revenue rose 22%, but GAAP operating profit fell 22%. The stock fell 6.95% after hours to 407.55, below the tracking pool's stop of 408.72, and the rating dropped to Sell.
- The 10-year Treasury yield fell 7bp over the week to 5.12%. The Hang Seng fell 1.3% to 23,867, and Lenovo dropped 9.98%.
- META, TSLA and LRCX report after the close on 10-21, and DHR reports pre-market. They will decide whether SOX holds 11,100.
By theme
AI
- Reported but unconfirmed by OpenAI: a "Terra" model series priced below GPT-6.1 Sol. Google's Gemini 4 Argon opened to developers on 10-13.
- The open-source model SAIL (35B total, 3B active parameters) scored 50.35 on SciCode, above the 744B GLM-5.2 at 47.57.
- The briefing argues value is settling at two ends: compute (chips, memory, optics, power) and distribution (Meta, Google, Tencent).
- Compute names are the cheapest by forward PE: Innolight 9.7, Eoptolink 8.4, and AVGO 17.2 with a Buy.
Robotics
- TSLA reports 10-21 after the close. At forward PE 172 and only 6.5% upside to the average target, it is priced as an option on Optimus and Robotaxi.
- ISRG da Vinci procedures grew 14% and Ion 31%. The stock fell on margins.
- Symbotic has 31.8% of its float sold short. UBTech rose 6.04% on twice average volume but stays below its 200-day line.
- Private funding: Dealroom puts humanoid VC at $8.7B for 2026 through 7-22, about two-thirds of it in China.
Space
- SpaceX's Super Intelligence (AI) segment became its largest, with revenue of about $7.56B. Starlink subscribers reached 13.6M.
- Rocket Lab (Watch) and AST SpaceMobile (Sell) sit near 52-week lows. ASTS trades at 139x sales with 21.7% of its float sold short.
- China Satellite is rated Sell at PE 576 and a 1.5% net margin, which the briefing calls a pure theme premium.
- LHX (Buy) and LMT (Buy, half position) are defensive space and missile exposure. LMT reports 10-22 pre-market.
Biotech
- The NASDAQ healthcare sector was the strongest on 10-20, up 2.03% on average. LLY hit an all-time intraday high of 1,311.75, with only 3.6% upside to the average target.
- Novo's CagriSema female study showed 25% weight loss over 68 weeks versus 3% for placebo. The market read it as the category expanding, not as a threat to LLY.
- OpenAI announced the acquisition of Orchestra Bio on 10-20 (terms undisclosed). VRTX's povetacicept PDUFA date is 11-30.
- Secondary-market AI drug developers look cheaper than private ones: RXRX has an EV of $1.48B versus private valuations of $1B–$3.8B.
Hong Kong, A-shares and crypto
- Hong Kong tech hardware led the decline. Tencent hit a 52-week low intraday at 406.4 and closed only 0.8 HKD above its 409.58 stop. Alibaba fell 3.58%. The Star 50 rose 1.0% while the ChiNext index fell 0.26%.
- The briefing flags large A/H gaps: SMIC's A-share is about 134% above its H-share, and BeiGene's about 36% above. WuXi AppTec's H-share is about 13.5% above its A-share.
- BTC rose 1.57% to 82,917.91 and holds above its 50- and 200-day lines. ETH, SOL, TAO and RENDER are rated Watch.
Rating highlights
| Ticker | Company | Call | Why |
|---|---|---|---|
| NVDA:NASDAQ | NVIDIA | Buy | Forward PE 13.6 with revenue growth of +106%; wait for a pullback to the 211–214 zone |
| MU:NASDAQ | Micron | Buy | Forward PE 4.3 prices in a post-2027 memory glut; insider selling seen as noise |
| AVGO:NASDAQ | Broadcom | Buy | Forward PE 17, 32% off its high, below both moving averages; build in 3 batches |
| SPCX:NASDAQ | SpaceX | Buy | First profit and AI segment ramp; do not chase after-hours; forward PE 72 |
| ISRG:NASDAQ | Intuitive Surgical | Sell (downgraded) | After-hours drop through the stop; GAAP operating profit -22% against forward PE 36 |
| ASTS:NASDAQ | AST SpaceMobile | Sell | 139x sales, new 52-week low, 22% short interest |
| 600118:SSE | China Satellite | Sell | PE 576 and 1.5% net margin; pure theme premium |
| GEV:NYSE | GE Vernova | Watch (downgraded) | Fell out of buy range; forward PE 35; earnings 10-28 pre-market |
| 0992:HKEX | Lenovo | Watch (downgraded) | Closed below the 25.82 stop after a 9.98% drop; trend broken |
| 300308:SZSE | Innolight | Buy | Forward PE 9.7 with revenue +175%; at the lower edge of the buy zone |
| 300502:SZSE | Eoptolink | Buy | Forward PE 8.4, net cash and no debt; stop 282.36 |
| LLY:NYSE | Eli Lilly | Hold | Only 3.6% target upside; raise trailing stop ahead of 10-29 earnings |
Tenbagger radar
- The briefing contains no ten-bagger radar section for this date, so there is no change to the watch pool.
Risks to watch
- Earnings: META, TSLA and LRCX on 10-21 after the close; LMT on 10-22; TER 10-27; MSFT and GOOGL 10-28; LLY 10-29. The 10-21 results could break SOX support at 11,100.
- Financing: Broadcom's CEO warned that financing could become the main headwind for the AI boom. The 10-year yield is above 5%, and SpaceX's $40B debt raise ties its AI spending to credit conditions.
- Stop levels: Tencent's close is 0.8 HKD above its stop, and Horizon Robotics (9660) and Innovent (1801) both traded below their stops intraday.
- Binary events: VRTX's povetacicept PDUFA on 11-30. For SpaceX, a lock-up expiry is flagged as medium-term supply pressure, with the date unverified.